Journal of Pharmaceutical Policy and Practice

Supply chain Management is critical to delivering quality and timely care to patients in healthcare. This became much more evident during the recent COVID-19 pandemic. Communications and connections between manufacturers, suppliers, and distributors is crucial for the timely movement of services, goods, and information to hospitals and healthcare facilities. Ideally, a good supply chain should be able to lower costs and improve patient care and safety by preventing delays in treatment.

Effective healthcare supply chain management usually results in better patient outcomes through the improvement of healthcare costs and access to necessary resources for health professionals. This Article Collection looks at the supply of vaccines and other health commodities, and factors affecting availability of commodities in East African countries.

We are looking for data collected from different Partner States (Burundi, Kenya, Rwanda, South Sudan, Tanzania, and Uganda) of the East African Community. Manuscripts are invited from authors affiliated to the East African Community Regional Center of Excellence for Vaccines, Immunization, and Health Supply Chain Management (EAC RCE – VIHSCM), a Regional Center hosted by the University of Rwanda and funded by the German Development Cooperation (GDC) through the German Development Bank (KfW). All manuscripts from research projects conducted as one of the requirements for the award of a master’s degree in health supply chain management by the EAC RCE – VIHSCM, College of Medicine and Health Sciences (CMHS) at the University of Rwanda.

---

Dr Asingizwe is a Research, Innovation, and Technical Assistance Coordinator in the EAC RCE-VIHSCM and a Senior Lecturer in the College of Medicine and Health Sciences (CMHS), University of Rwanda. She has a PhD in Public Health. She has over ten years of experience in Research and she serves as a Deputy Editor of the Rwanda Journal of Medicine and Health Sciences since 2022. She has published in multiple venues, and she has been involved in implementation research that feeds into evidence-based health care policy and practice as foundational to cost-effective targeted interventions for optimal population health outcomes.

 

Prof.  Zachariah Nazar is an Assistant Professor of Clinical Pharmacy & Practice at the College of Pharmacy, Qatar University and has a clinical role as a PharmD preceptor in Hamad Medical Corporation Drug Information Department (CPD). He has accumulated over 13 years of experience in various fields of academic and clinical pharmacy. Dr Zachariah currently acts as the Head of Continuous Professional Development at Qatar University and serves as deputy-head of the Education Committee of the European Society of Clinical Pharmacy. He is a member of the UK Emergency Medical Team having completed his deployment training in 2018 and delivers consultancy on their pharmacy operations.
Dr Zachariah’s research areas include drug formulary management, pharmacy education and ADR reporting. He has published over 30 peer-reviewed articles and book chapters, and has an established track record of research grant awards.

 

Prof. Zaheer Babar comes with over two decades of working in academia in Universities in United Kingdom, New Zealand and Malaysia. A pharmacist by training and a PhD in pharmaceutical policy, Prof. Babar is the recipient of the prestigious “Research Excellence Award” from The University of Auckland in 2012. His research programme covers areas related to pharmaceutical policy and practice, encompassing access and affordability of medicines, quality use of medicines and pharmacoeconomics. He has a successful track record of attracting national and international funding in these areas of medicines policy.

Prof. Babar has active research linkages with the leading universities in Australia, Europe and in the Asia Pacific Region and has acted as a consultant for World Health Organization, Health Action International, International Union against Tuberculosis and Lung Disease, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand. He is a reviewer of top tier health policy journals and of funding bodies including Australian National Health and Medical Research Council. Prof. Babar is the founding editor of Journal of Pharmaceutical Policy and Practice (www.joppp.org)

 

Dr. Asingizwe, Prof. Nazar and Prof. Babar declares no conflict of interest.

Instructions for AuthorsSubmit an Article